Mostrar el registro sencillo del ítem

dc.contributor.authorDelgado-Gonzalez, Antonio
dc.contributor.authorRobles Remacho, Agustín 
dc.contributor.authorMarín Romero, Antonio
dc.contributor.authorDe Miguel Pérez, Diego
dc.contributor.authorGuardia Monteagudo, Juan José
dc.contributor.authorFara, Mario A.
dc.contributor.authorSánchez Martín, Rosario María 
dc.contributor.authorDíaz Mochón, Juan José 
dc.date.accessioned2024-02-07T12:07:11Z
dc.date.available2024-02-07T12:07:11Z
dc.date.issued2019-08-01
dc.identifier.citationDelgado-Gonzalez, A. , Robles-Remacho, A. , Marin-Romero, A. , ... Sanchez-Martin, R.M. , Diaz-Mochon, J.J. Talanta, 2019, 200, pp. 51–56es_ES
dc.identifier.urihttps://hdl.handle.net/10481/88591
dc.description.abstractmiRNAs play pivotal roles in various biological contexts, particularly in disease. Notably, miRNA-21 is implicated in severe pathological conditions, necessitating accurate quantification for medical diagnostics. Existing miRNA quantification techniques often fall short. Here, we introduce a novel, dynamic chemistry-based, PCR-free method for rapid and cost-effective miRNA-21 identification and quantification directly from tumor cells, employing FACS and fluorescent microplate assays. This approach, utilizing bead-based reagents, enables precise quantification of miR-21 molecules in MDA-MB-468 and H1975 tumor cells.es_ES
dc.description.sponsorshipThis research was supported by the Regional Government, Spain(BIO-1778) and the Ministry of Economy and Competitiveness, Spain(BIO2016-80519-R – FJLD is supported by Torres Quevedo fellowship,SpainPTQ-16-08597).ADGandARRaresupportedbySpanishMinistryof Education, Spain (PhD scholarships FPU14/02181 and FPU15/06418, respectively). AMR thanks DestiNA Genomics, Spain and theUniversity of Granada, Spain for a PhD scholarship (P26 KnowledgeTransferProgramme)DMPacknowledgestheUniversityofGranadaforhis predoctoral research contract. SD's work was supported by in-tramural funding from the University of Trento, Italy. DestiNA's staffand SD thank the miRNADisEASY Consortium (EU, European UnionH2020-MSCA-RISE 2015 (Grant no. 690866)). We would also like tothank all the healthy volunteers who participated in this study.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titlePCR-free and chemistry-based technology for miR-21 rapid detection directly from tumour cellses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/embargoedAccesses_ES
dc.identifier.doihttps://doi.org/10.1016/j.talanta.2019.03.039
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional